Table 2.

Benefits and harms of the HPV vaccines: number of pages obtained of clinical study reports from the European Medicines Agency and GlaxoSmithKline

	HPV vaccine manufacturer	Study programme ID	Total pages obtained	European Medicines Agency	GlaxoSmithKline
1	GlaxoSmithKline	HPV-001	5813	5813	0
2	GlaxoSmithKline	HPV-003	799	0	799
3	GlaxoSmithKline	HPV-008	11,456	4263	7193
4	GlaxoSmithKline	HPV-013	8323	382	7941
5	GlaxoSmithKline	HPV-015	6290	543	5747
6	GlaxoSmithKline	HPV-023	936	0	936
7	GlaxoSmithKline	HPV-029	1543	0	1543
8	GlaxoSmithKline	HPV-030	1351	0	1351
9	GlaxoSmithKline	HPV-031	476	0	476
10	GlaxoSmithKline	HPV-032	2912	0	2912
11	GlaxoSmithKline	HPV-033	587	0	587
12	GlaxoSmithKline	HPV-035	451	0	451
13	GlaxoSmithKline	HPV-038	957	0	957
14	GlaxoSmithKline	HPV-040	2892	128	2764
15	GlaxoSmithKline	HPV-058	1745	0	1745
16	GlaxoSmithKline	HPV-063	1474	0	1474
17	GlaxoSmithKline	HPV-069	819	0	819
18	Merck Sharp and Dohme	V501-005	357	357	0
19	Merck Sharp and Dohme	V501-013	1797	1797	0
20	Merck Sharp and Dohme	V501-015	713	713	0
21	Merck Sharp and Dohme	V501-018	1014	1014	0
22	Merck Sharp and Dohme	V501-019	2645	2645	0
23	Merck Sharp and Dohme	V501-020	2595	2595	0
24	Merck Sharp and Dohme	V503-006	467	467	0
	Total pages obtained		58,412	20,717	37,695